➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKesson
McKinsey
Dow
Medtronic

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

ATROPEN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Atropen patents expire, and what generic alternatives are available?

Atropen is a drug marketed by Meridian Medcl Techn and is included in one NDA.

The generic ingredient in ATROPEN is atropine. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine profile page.

Drug patent expirations by year for ATROPEN
Recent Clinical Trials for ATROPEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Craig J. HuangN/A
University of PittsburghPhase 1
MicroDose Defense Products L.L.C.Phase 1

See all ATROPEN clinical trials

US Patents and Regulatory Information for ATROPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-004 Sep 17, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-003 Jun 19, 2003 RX Yes Yes   Start Trial   Start Trial   Start Trial
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-002 Jun 19, 2003 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Moodys
AstraZeneca
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.